Study reveals new way to target HER2-negative metastatic breast cancer

[News]

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

More... (https://www.news-medical.net/news/20180920/Study-reveals-new-way-to-target-HER2-negative-metastatic-breast-cancer.aspx)